Global Commercial Aquaculture Vaccines Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Commercial Aquaculture Vaccines Market Research Report 2024
Commercial Aquaculture Vaccines Are Approved Vaccines That Can Induce Protective Immune Responses In Aquatic Animals. The Mass Production Of Aquatic Species Leads To Changes In Optimal Breeding Conditions, Which Indicates Increased Sensitivity To Infectious/Viral Diseases, Thereby Increasing Increased Demand For Commercial Aquaculture Vaccines, Bacterial Diseases And Zoonotic Infections, Are Major Obstacles To Successful Aquaculture. Facts Have Proved That Commercial Aquaculture Vaccines Are A Better Alternative To Antibiotics Used In Fish Aquaculture, Because Antibiotic Treatment Has Attracted A Lot Of Attention Due To Adverse Effects Such As Bacterial Resistance, Toxicity, And Residual Antibiotics In Aquaculture Food. In Addition, The Increase In Global Fish Consumption And The Prevalence Of Bacterial Infections Between Aquatic Species Are Also Increasing The Use Of Commercial Fish Aquaculture Vaccines.
According to Mr Accuracy reports’s new survey, global Commercial Aquaculture Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Commercial Aquaculture Vaccines market research.
Key manufacturers engaged in the Commercial Aquaculture Vaccines industry include Zoetis LLC, Merck & Co. Inc. (MSD Animal Health), Laboratorios Hipra S. A., Elanco Animal Health Inc, Veterquimica S. A., Ictyogroup, Tecnovax and Nisseiken Co Ltd, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Commercial Aquaculture Vaccines were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Commercial Aquaculture Vaccines market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Commercial Aquaculture Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Zoetis LLC
Merck & Co. Inc. (MSD Animal Health)
Laboratorios Hipra S. A.
Elanco Animal Health Inc
Veterquimica S. A.
Ictyogroup
Tecnovax
Nisseiken Co Ltd
Segment by Type
Nucleic Acid Vaccine
Subunit Vaccine
Live Attenuated Vaccine
Inactivated Vaccine
Fisheries
Breeding Clinic
Fisheries Research Institute
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Commercial Aquaculture Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Commercial Aquaculture Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Commercial Aquaculture Vaccines market research.
Key manufacturers engaged in the Commercial Aquaculture Vaccines industry include Zoetis LLC, Merck & Co. Inc. (MSD Animal Health), Laboratorios Hipra S. A., Elanco Animal Health Inc, Veterquimica S. A., Ictyogroup, Tecnovax and Nisseiken Co Ltd, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Commercial Aquaculture Vaccines were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Commercial Aquaculture Vaccines market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Commercial Aquaculture Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Zoetis LLC
Merck & Co. Inc. (MSD Animal Health)
Laboratorios Hipra S. A.
Elanco Animal Health Inc
Veterquimica S. A.
Ictyogroup
Tecnovax
Nisseiken Co Ltd
Segment by Type
Nucleic Acid Vaccine
Subunit Vaccine
Live Attenuated Vaccine
Inactivated Vaccine
Segment by Application
Fisheries
Breeding Clinic
Fisheries Research Institute
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Commercial Aquaculture Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source